Adar1 Capital Management
$1.6B Assets Reported
315 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| ABVX | ABIVAX SA | 1,438,019 | $160M | 10.1% |
| PTGX | PROTAGONIST THERAPEUTICS INC | 994,119 | $105M | 6.6% |
| ROIV | ROIVANT SCIENCES LTD | 3,285,906 | $91M | 5.7% |
| IMVT | IMMUNOVANT INC | 2,679,010 | $67M | 4.2% |
| SPY | STATE STR SPDR S&P 500 ETF T | 75,940 | $49M | 3.1% |
| CYTK | CYTOKINETICS INC | 632,556 | $42M | 2.6% |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,139,331 | $41M | 2.6% |
| BOXX | EA SERIES TRUST | 337,125 | $39M | 2.5% |
| DNLI | DENALI THERAPEUTICS INC | 1,871,455 | $36M | 2.3% |
| BEAM | BEAM THERAPEUTICS INC | 1,446,375 | $34M | 2.2% |
Track Adar1 Capital Management's 13F portfolio: $1.6B in reported holdings, 315 positions. Top holdings, AUM, and quarterly changes on SentiSense.